cognitive status will be conducted with the Short Portable Mental Status Questionnaire SPMSQ preoperative and 2 hours after surgery.
The Effect of Ketamine on Postoperative Cognitive Dysfunction.
Brief Summary
Available evidence suggests that there is no significant difference in the incidence of postoperative cognitive dysfunction POCD when general anaesthesia and regional anaesthesia are compared\[13, 14\]. To the knowledge of the investigators , no studies are examining the effects of ketamine on cognitive outcomes in the setting of spinal anesthesia.
Thus, the purpose of this study was to compare the cognitive status, as assessed by the SPMSQ, of elderly patients undergoing orthopaedic surgery under spinal anaesthesia before and after ketamine administration. The authors hypothesized that patients receiving ketamine would exhibit better cognitive performance.
Intervention / Treatment
-
Ketamine (DRUG)ketamine will be administered at a dose of 0.3 mg/kg in normal saline at 0.9% (250 mL)
-
Placebo (OTHER)the control group will receive only normal saline at 0.9%, with the same physical characteristics of the ketamine solution
Condition or Disease
- Postoperative Cognitive Dysfunction
Phase
Study Design
Study type: | INTERVENTIONAL |
---|---|
Status: | Completed |
Study results: | No Results Available |
Age: | 60 Years and older (Adult, Older Adult) |
Enrollment: | 45 (ACTUAL) |
Funded by: | Other |
Allocation: | Randomized |
Primary Purpose: | Prevention |
MaskingTRIPLE:
|
Clinical Trial Dates
Start date: | Dec 10, 2020 | ACTUAL |
---|---|---|
Primary Completion: | Mar 08, 2022 | ACTUAL |
Completion Date: | Mar 09, 2022 | ACTUAL |
Study First Posted: | Mar 25, 2020 | ACTUAL |
Results First Posted: | Aug 31, 2020 | |
Last Updated: | May 06, 2022 |
Sponsors / Collaborators
Lead Sponsor:
Assiut University
Responsible Party:
N/A
Location
Participant Groups
-
No description provided
-
No description provided
Eligibility Criteria
Sex: | All |
---|---|
Minimum Age: | 60 |
Age Groups: | Adult / Older Adult |
Healthy Volunteers: | Yes |
Inclusion Criteria:
* patients scheduled for orthopaedic surgery under spinal anaesthesia.
* ASA physical status I to II.
Exclusion Criteria:
* Patients with a history of psychosis, schizophrenia, nephropathy, uncontrolled blood pressure, uncontrolled hepatic disorders, or allergy to ketamine.
* Patients With moderate to severe depression according to Yesavage abbreviated Geriatric Depression Scale,
* Patients presented with postoperative delirium or required medications other than study drugs.
* Ketamine administration is contraindicated.
* patients scheduled for orthopaedic surgery under spinal anaesthesia.
* ASA physical status I to II.
Exclusion Criteria:
* Patients with a history of psychosis, schizophrenia, nephropathy, uncontrolled blood pressure, uncontrolled hepatic disorders, or allergy to ketamine.
* Patients With moderate to severe depression according to Yesavage abbreviated Geriatric Depression Scale,
* Patients presented with postoperative delirium or required medications other than study drugs.
* Ketamine administration is contraindicated.
Primary Outcomes
More Details
NCT Number: | NCT04321746 |
---|---|
Other IDs: | Ketamine |
Study URL: | https://clinicaltrials.gov/study/NCT04321746 |
Last updated: Sep 29, 2023